Press Releases from DelveInsight Business Research (5349 total)
Facioscapulohumeral Muscular Dystrophy Market Anticipated to Expand Rapidly Duri …
DelveInsight's "Facioscapulohumeral Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Facioscapulohumeral Muscular Dystrophy, historical and forecasted epidemiology as…
Myasthenia Gravis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, USA) As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Myasthenia Gravis therapeutics landscape…
Microsatellite Stable Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA App …
(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Microsatellite Stable Colorectal…
Galactosemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
(Albany, USA) As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Galactosemia therapeutics landscape…
Chronic Rhinosinusitis with Nasal Polyps Clinical Trials 2024: EMA, PDMA, FDA Ap …
(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Chronic Rhinosinusitis with…
Asthma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, The …
(Albany, USA) DelveInsight's 'Asthma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline asthma therapies in various stages of clinical development,…
Acromegaly Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, Thera …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acromegaly pipeline constitutes 12+ key companies continuously working towards developing 13+ Acromegaly treatment therapies,…
Actinic Keratosis Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Actinic Keratosis pipeline constitutes 10+ key companies continuously working towards developing 10+ Actinic Keratosis…
Chemotherapy Induced Anemia Pipeline Overview 2024: FDA Approvals and Key Develo …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chemotherapy Induced Anemia pipeline constitutes 3+ key companies continuously working towards developing 3+ Chemotherapy…
Alpha-1 Antitrypsin Deficiency Pipeline Analysis 2024: FDA Approvals and Emergin …
Alpha-1 Antitrypsin Deficiency pipeline constitutes 12+ key companies continuously working towards developing 12+ Alpha-1 Antitrypsin Deficiency treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Alport Syndrome Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therap …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alport Syndrome pipeline constitutes 8+ key companies continuously working towards developing 10+ Alport Syndrome…
Cancer Anorexia Market to Reach New Heights in Growth by 2034, DelveInsight Pred …
DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as…
CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Pipeline 2024: Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CAR T-Cell Therapy For Acute Lymphoblastic Leukemia pipeline constitutes 5+ key companies continuously working…
Neurofibromatosis Type 2 Pipeline Analysis 2024: FDA Approvals and Emerging Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neurofibromatosis Type 2 pipeline constitutes 5+ key companies continuously working towards developing 5+ Neurofibromatosis…
Chronic Refractory Cough Pipeline Assessment 2024: Therapies, Clinical Trials, a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Refractory Cough pipeline constitutes 4+ key companies continuously working towards developing 4+ Chronic…
Chronic Wounds Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, Me …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 3+ key companies continuously working towards developing 3+ Chronic Wounds…
Dry Age-related Macular Degeneration Clinical Trials 2024: EMA, PMDA, FDA Approv …
(Albany, USA) Dry Age-related Macular Degeneration Pipeline includes 40+ key companies continuously working towards developing 40+ Dry Age-related Macular Degeneration treatment therapies, analyses DelveInsight
DelveInsight's 'Dry…
Checkpoint Inhibitors Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, C …
(Albany, USA) Checkpoint Inhibitors companies are BeBetter Med, BIOCAD, CanBas Co., Ltd., Laekna Therapeutics, Genentech, Alphamab Oncology, Hangzhou Sumgen Biotech, Harbour BioMed, Aurigene Discovery Technologies,…
Myopia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Me …
(Albany, USA) As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in the Myopia therapeutics landscape…
Chemotherapy Induced Peripheral Neuropathy Pipeline Trends 2024: Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chemotherapy Induced Peripheral Neuropathy pipeline constitutes 10+ key companies continuously working towards developing 11+…
Community-Acquired Bacterial Pneumonia Pipeline Update 2024: FDA Approvals, Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Community-Acquired Bacterial Pneumonia pipeline constitutes key companies continuously working towards developing Community-Acquired Bacterial Pneumonia…
Facioscapulohumeral Muscular Dystrophy Pipeline Assessment 2024: Therapies, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Facioscapulohumeral Muscular Dystrophy pipeline constitutes 10+ key companies continuously working towards developing 10+ Facioscapulohumeral…
Familial Chylomicronemia Syndrome Pipeline Analysis 2024: FDA Approvals and Emer …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Familial Chylomicronemia Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Familial…
Hypercholesterolemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypercholesterolemia pipeline constitutes 25+ key companies continuously working towards developing 30+ Hypercholesterolemia treatment therapies,…
Cystic Fibrosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Cystic Fibrosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Cystic Fibrosis treatment therapies, analysis…
Acute Ischemic Stroke Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication …
(Albany, USA) As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Acute Ischemic Stroke…
Bronchopulmonary Dysplasia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's, "Bronchopulmonary Dysplasia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Bronchopulmonary Dysplasia pipeline landscape. It…
Critical Limb Ischemia Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinica …
(Albany, United States) As per DelveInsight's assessment, globally, Critical Limb Ischemia pipeline constitutes 10+ key companies continuously working towards developing 15+ Critical Limb Ischemia treatment…
Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, United States) Colorectal Cancer pipeline constitutes 195+ key companies continuously working towards developing 200+ Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism…
Cell and Gene Therapies in Rare Disorders Market to Reach New Heights in Growth …
DelveInsight's "Cell and Gene Therapies in Rare Disorders Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cell and Gene Therapies…
Generalized Anxiety Disorder Pipeline 2024: Clinical Trials Assessment, FDA Appr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized…
Multiple Myeloma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Myeloma pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Myeloma…
Multiple System Atrophy Pipeline Update 2024: FDA Approvals, Therapeutic Advance …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple…
Metastatic Prostate Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approv …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Prostate Cancer pipeline constitutes 80+ key companies continuously working towards developing 85+ Metastatic…
Acute Pancreatitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Companies, Me …
(Albany, United States) As per DelveInsight's assessment, globally, Acute Pancreatitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Acute Pancreatitis treatment therapies, analysis…
Chemotherapy Induced Peripheral Neuropathy Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, United States) As per DelveInsight's assessment, globally, Chemotherapy Induced Peripheral Neuropathy pipeline constitutes 10+ key companies continuously working towards developing 11+ Chemotherapy Induced Peripheral…
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Companies, Me …
(Albany, USA) "Cholangiocarcinoma Pipeline Insight 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cholangiocarcinoma Market.
The…
Congenital Adrenal Hyperplasia Clinical Trials 2024: EMA, PDMA, FDA Approvals, C …
(Albany, United States) Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards developing 8+ Congenital Adrenal Hyperplasia treatment therapies, analysis of Clinical Trials,…
Corneal Ulcer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, USA) DelveInsight's, "Corneal Ulcer Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Corneal Ulcer pipeline landscape. It…
Ulcerated Necrobiosis Lipoidica Market is Predicted to Exhibit Remarkable Growth …
DelveInsight's "Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as…
Underactive Bladder Market Growth to Accelerate in Forecast Period (2024-2034), …
DelveInsight's "Underactive Bladder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Underactive Bladder, historical and forecasted epidemiology as well as…
WHIM Syndrome Pipeline Analysis 2024: FDA Approvals and Emerging Therapies, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, WHIM Syndrome pipeline constitutes key companies continuously working towards developing WHIM Syndrome treatment therapies,…
Cancer Vaccines Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines…
CDKL5 Deficiency Disorder Pipeline 2024: Clinical Trials Assessment, FDA Approva …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CDKL5 Deficiency Disorder pipeline constitutes 7+ key companies continuously working towards developing 8+ CDKL5…
Menkes Disease Market 2034: Epidemiology Review, Pipeline Breakthroughs, Regulat …
DelveInsight's "Menkes Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as…
Microscopic Polyangiitis Market 2034: Epidemiology Trends, Innovative Therapies, …
DelveInsight's "Microscopic Polyangiitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Microscopic Polyangiitis, historical and forecasted epidemiology as well as…
Migraine Pipeline Analysis 2024: FDA Approvals and Emerging Therapies | GlaxoSmi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies,…
Influenza Pipeline Insights 2024: Therapies, Clinical Trials, Therapies, Mechani …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies,…
Severe Asthma Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapie …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Severe Asthma pipeline constitutes key companies continuously working towards developing Severe Asthma treatment therapies,…
Vascular Dementia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, United States) As per DelveInsight's assessment, globally, Vascular Dementia pipeline constitutes 11+ key companies continuously working towards developing 11+ Vascular Dementia treatment therapies, analysis…
